Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (FY)Jun 30, 2021 | (Q4)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -77.57%16.15M | -77.57%16.15M | 217.15%71.98M | 217.15%71.98M | 152.77%22.7M | 152.77%22.7M | 17.13%8.98M | 17.13%8.98M | -49.30%7.67M | -49.30%7.67M |
| -Cash and cash equivalents | -77.57%16.15M | -77.57%16.15M | 217.15%71.98M | 217.15%71.98M | 152.77%22.7M | 152.77%22.7M | 17.13%8.98M | 17.13%8.98M | -49.30%7.67M | -49.30%7.67M |
| Receivables | 43.45%4M | 43.45%4M | 32.65%2.79M | 32.65%2.79M | 45.00%2.1M | 45.00%2.1M | 24.16%1.45M | 24.16%1.45M | 8.86%1.17M | 8.86%1.17M |
| -Other receivables | 43.45%4M | 43.45%4M | 32.65%2.79M | 32.65%2.79M | 45.00%2.1M | 45.00%2.1M | 24.16%1.45M | 24.16%1.45M | 8.86%1.17M | 8.86%1.17M |
| Non current assets | ||||||||||
| -Long term equity investment | 73.02%1.03B | 73.02%1.03B | 30.54%597.78M | 30.54%597.78M | -3.15%457.94M | -3.15%457.94M | 17.48%472.83M | 17.48%472.83M | 4.11%402.49M | 4.11%402.49M |
| Total assets | 56.01%1.06B | 56.01%1.06B | 38.39%679.1M | 38.39%679.1M | -0.39%490.73M | -0.39%490.73M | 17.22%492.63M | 17.22%492.63M | 1.81%420.26M | 1.81%420.26M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 44.03%7.51M | 44.03%7.51M | 32.06%5.22M | 32.06%5.22M | 27.43%3.95M | 27.43%3.95M | 19.10%3.1M | 19.10%3.1M | 50.75%2.6M | 50.75%2.6M |
| -accounts payable | 57.00%650K | 57.00%650K | 35.74%414K | 35.74%414K | -0.33%305K | -0.33%305K | 16.35%306K | 16.35%306K | 1.94%263K | 1.94%263K |
| -Dividends payable | 42.77%6.66M | 42.77%6.66M | 31.38%4.66M | 31.38%4.66M | 32.71%3.55M | 32.71%3.55M | 20.17%2.68M | 20.17%2.68M | 61.19%2.23M | 61.19%2.23M |
| -Other payable | 47.45%202K | 47.45%202K | 45.74%137K | 45.74%137K | -20.34%94K | -20.34%94K | 4.42%118K | 4.42%118K | 29.89%113K | 29.89%113K |
| Non current liabilities | ||||||||||
| Total liabilities | 44.03%7.51M | 44.03%7.51M | 32.06%5.22M | 32.06%5.22M | -22.55%3.95M | -22.55%3.95M | 95.96%5.1M | 95.96%5.1M | 50.75%2.6M | 50.75%2.6M |
| Shareholders'equity | ||||||||||
| Share capital | 56.11%1.05B | 56.11%1.05B | 38.44%673.89M | 38.44%673.89M | -0.15%486.78M | -0.15%486.78M | 16.73%487.54M | 16.73%487.54M | 1.61%417.65M | 1.61%417.65M |
| -common stock | 56.11%1.05B | 56.11%1.05B | 38.44%673.89M | 38.44%673.89M | -0.15%486.78M | -0.15%486.78M | 16.73%487.54M | 16.73%487.54M | 1.61%417.65M | 1.61%417.65M |
| Total stockholders'equity | 56.11%1.05B | 56.11%1.05B | 38.44%673.89M | 38.44%673.89M | -0.15%486.78M | -0.15%486.78M | 16.73%487.54M | 16.73%487.54M | 1.61%417.65M | 1.61%417.65M |
| Total equity | 56.11%1.05B | 56.11%1.05B | 38.44%673.89M | 38.44%673.89M | -0.15%486.78M | -0.15%486.78M | 16.73%487.54M | 16.73%487.54M | 1.61%417.65M | 1.61%417.65M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |